Subcutaneous metastasis from an ovarian carcinoma disappeared following tamoxifen therapy.
In a 78-year-old woman who had been treated for a breast cancer, a subcutaneous metastasis was diagnosed. This metastasis disappeared following a 3-months' treatment with tamoxifen. Only then was the primary tumour found to be ovarian carcinoma rather than a mammary one. This and other reports indicate that hormonal agents may also be considered as a third line of treatment in ovarian carcinoma.
Flam
F
F
Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden.
Skoog
L
L
Wilking
N
N
D000368:Aged; D001943:Breast Neoplasms; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009378:Neoplasms, Multiple Primary; D010051:Ovarian Neoplasms / Q000473:pathology*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D013629:Tamoxifen / Q000627:therapeutic use*; D016896:Treatment Outcome; D014472:Umbilicus
D004965:Estrogen Antagonists; D013629:Tamoxifen